Castle Biosciences CSTL Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $63.76M-28.9% | $116.73M-2.5% | $85.56M-9.9% | $82.23M-3.9% | $89.69M+8.1% | ||
| $5.6M-96.9% | $5.59M— | $5.58M-97.0% | $184.81M+6.1% | $183.33M+17.3% | ||
| $42.26M-25.0% | $43.38M-15.3% | $49.48M-1.5% | $52.31M+13.7% | $56.35M+32.0% | ||
| $10.46M+52.7% | $10.25M+26.0% | $8.65M+31.6% | $8.37M+4.4% | $6.85M-10.4% | ||
| $328.9M-5.9% | $361.1M+0.3% | $357.57M+3.7% | $348.67M+8.8% | $349.39M+18.1% | ||
| $100.93M+82.1% | $97.44M+90.6% | $84.89M+91.3% | $74.06M+91.7% | $55.42M+68.4% | ||
| $10.7M0.0% | $10.7M0.0% | $10.7M0.0% | $10.7M0.0% | $10.7M0.0% | ||
| $86.66M+28.9% | $88.88M-7.0% | $91.16M-8.7% | $93.43M-8.5% | $67.21M-35.6% | ||
| $547.81M+9.2% | $578.56M+8.9% | $562.79M+9.4% | $544.73M+11.8% | $501.72M+9.4% | ||
| $15.04M+76.9% | $18.71M+171% | $12.21M+79.3% | $13.18M+38.2% | $8.5M-8.8% | ||
| $1.67M+50.0% | $417K+50.0% | $0— | $1.94M— | $1.11M— | ||
| $48.76M+30.8% | $68.68M+39.0% | $55.31M+24.9% | $50.89M+29.0% | $37.27M+16.6% | ||
| $8.4M-5.9% | $9.64M-1.1% | $10.05M+0.3% | $8.1M— | $8.92M— | ||
| $86.39M+40.7% | $107.68M+42.8% | $95.74M+30.2% | $89.35M+40.9% | $61.41M+9.6% | ||
| $30K+3.4% | $30K+7.1% | $29K+3.6% | $29K+3.6% | $29K+3.6% | ||
| -$238.81M-5.7% | -$224.28M-12.1% | -$221.95M-5.8% | -$221.45M-4.5% | -$225.97M-2.3% | ||
| $461.42M+4.8% | $470.87M+3.3% | $467.05M+5.9% | $455.38M+7.4% | $440.31M+9.4% | ||
| $547.81M+9.2% | $578.56M+8.9% | $562.79M+9.4% | $544.73M+11.8% | $501.72M+9.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Castle Biosciences's total assets?
- Castle Biosciences (CSTL) holds $547.8M in total assets, up 9.2% year over year.
- How much debt does Castle Biosciences have?
- Castle Biosciences carries $36.7M in total debt against $461.4M of shareholders' equity, a debt-to-equity ratio of 0.08.
- How much cash does Castle Biosciences have?
- Castle Biosciences holds $63.8M in cash and equivalents.
- Can Castle Biosciences cover its short-term obligations?
- Its current ratio is 6.75 — current assets exceed current liabilities.
- Where does Castle Biosciences's balance sheet data come from?
- Every line is extracted from Castle Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
